Autopsy report · NCT00931411
Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis
Cause of deathSlow enrollment
“Patients would improve naturally due to weather conditions”
Life of this trial
- Registered 5 months after it had already started.
- Ran for about 6 months before it stopped.
- 73 participants enrolled.
- Results were posted on the registry 1 year 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Cosmetique Active International
- Sponsor type
- Industry
- Conditions
- Atopic Dermatitis
- Interventions
- Formulation 609580 20; Formulation 609209 (Lipikar Baume)
- Participants
- 73
- Sites
- 5
- Countries
- Canada
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.